Angel Investment through Alumni Ventures and Direct

Vivo Capital is a healthcare investment firm that seeks to invest in exciting healthcare companies which may include therapeutics, medical devices, pharma related services, and tools and diagnostics. ...

Ventalis is developing a potential best in class hedgehog inhibitor for Pulmonary Fibrosis

We invest in early stage growth companies that are approaching a key inflection point in their development.

VUGENE is an AI-integrated multi-omic data interpretation platform for therapeutic R&D. We turn complex biological datasets into clear mechanism-of-action (MoA) insights in days instead of months. The ...

Headquartered in Florida with scientific operations in Sweden, Vycellix is a biotechnology company with the mission to deliver superior outcomes for patients through the delivery of highly innovative ...

Vincere is advancing disease-modifying small molecules for Parkinson’s by boosting mitophagy. Currently in the IND-enabling phase, our highly potent and selective USP30 inhibitors are nearing the idea ...

The Virginia Biotechnology Association, formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia.

Virginia Venture Partners is an equity investment program of the Virginia Innovation Partnership Corporation

VAMTAJ is the single-family office of an innovative French entrepreneur. Biotech investment is a key focus of our Private Equity strategy. We invest in funds and direct participation.